1α,25-dihydroxyvitamin D3 protects retinal ganglion cells in glaucomatous mice
Francesca Lazzara(University of Catania), Claudio Bucolo(University of Catania)
Cited by 27
Related Papers
Molecular features of interaction between VEGFA and anti-angiogenic drugs used in retinal diseases: a computational approach
|Frontiers in Pharmacology|2015|83
A New Human Blood–Retinal Barrier Model Based on Endothelial Cells, Pericytes, and Astrocytes
|International Journal of Molecular Sciences|2020|78
Gabapentin Attenuates Ocular Inflammation: In vitro and In vivo Studies
|Frontiers in Pharmacology|2017|54
Brimonidine is Neuroprotective in Animal Paradigm of Retinal Ganglion Cell Damage
|Frontiers in Pharmacology|2021|45
Vitamin D3 preserves blood retinal barrier integrity in an in vitro model of diabetic retinopathy
|Frontiers in Pharmacology|2022|35